ATE169618T1 - Piperidinylamide, sulfonamide und sulfoxamide als inhibitoren der cholesterin biosynthese - Google Patents
Piperidinylamide, sulfonamide und sulfoxamide als inhibitoren der cholesterin biosyntheseInfo
- Publication number
- ATE169618T1 ATE169618T1 AT93914338T AT93914338T ATE169618T1 AT E169618 T1 ATE169618 T1 AT E169618T1 AT 93914338 T AT93914338 T AT 93914338T AT 93914338 T AT93914338 T AT 93914338T AT E169618 T1 ATE169618 T1 AT E169618T1
- Authority
- AT
- Austria
- Prior art keywords
- inhibitors
- piperidinylamides
- sulfoxamides
- sulfonamides
- cholesterol biosynthesis
- Prior art date
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title abstract 5
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 235000012000 cholesterol Nutrition 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 229940124530 sulfonamide Drugs 0.000 title 1
- 150000003456 sulfonamides Chemical class 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- LWMPFIOTEAXAGV-UHFFFAOYSA-N piperidin-1-amine Chemical class NN1CCCCC1 LWMPFIOTEAXAGV-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other Liquid Machine Or Engine Such As Wave Power Use (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91060492A | 1992-07-08 | 1992-07-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE169618T1 true ATE169618T1 (de) | 1998-08-15 |
Family
ID=25429048
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93914338T ATE169618T1 (de) | 1992-07-08 | 1993-06-03 | Piperidinylamide, sulfonamide und sulfoxamide als inhibitoren der cholesterin biosynthese |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US5350758A (de) |
| EP (1) | EP0650474B1 (de) |
| JP (1) | JPH07508732A (de) |
| KR (1) | KR100286410B1 (de) |
| AT (1) | ATE169618T1 (de) |
| AU (1) | AU678973B2 (de) |
| CA (1) | CA2136841C (de) |
| DE (1) | DE69320352T2 (de) |
| ES (1) | ES2120506T3 (de) |
| IL (1) | IL106237A0 (de) |
| MX (1) | MX9304070A (de) |
| NZ (1) | NZ253592A (de) |
| WO (1) | WO1994001404A1 (de) |
| ZA (1) | ZA934777B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6103733A (en) * | 1998-09-09 | 2000-08-15 | Bachmann; Kenneth A. | Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes |
| KR100601501B1 (ko) * | 2004-09-24 | 2006-07-18 | 삼성에스디아이 주식회사 | 이차전지의 팩 케이스 |
| US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
| US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
| ATE547394T1 (de) | 2006-12-01 | 2012-03-15 | Bristol Myers Squibb Co | N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen |
| WO2011145022A1 (en) | 2010-05-21 | 2011-11-24 | Pfizer Inc. | 2-phenyl benzoylamides |
| US20130345392A1 (en) | 2011-03-04 | 2013-12-26 | Pfizer Inc | Edn3-like peptides and uses thereof |
| CN105143203A (zh) | 2013-04-17 | 2015-12-09 | 辉瑞大药厂 | 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 |
| WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
| WO2020150473A2 (en) | 2019-01-18 | 2020-07-23 | Dogma Therapeutics, Inc. | Pcsk9 inhibitors and methods of use thereof |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2580411A (en) * | 1948-10-23 | 1952-01-01 | Searle & Co | Dihexyl alanine dialkylamides |
| FR1261160A (fr) * | 1955-07-28 | 1961-05-19 | Procédé de préparation de n-t-alkyl-dialkylamino-amides | |
| NL109859C (de) * | 1957-09-27 | |||
| US3185678A (en) * | 1961-08-04 | 1965-05-25 | Colgate Palmolive Co | Polymethyleniminoalkylamides |
| US3178439A (en) * | 1963-05-06 | 1965-04-13 | Reilly Tar & Chem Corp | N-alkanoyl and alkenoyl hydroxy alkyl piperidides |
| CH448086A (de) * | 1965-01-15 | 1967-12-15 | Geigy Ag J R | Verfahren zur Herstellung von neuen Derivaten des 1,2,3,6-Tetrahydro-pyridins |
| DE1719388B2 (de) * | 1968-02-09 | 1976-04-29 | Bayer Ag, 5090 Leverkusen | Verfahren zum faerben von fasermaterialien aus polyacrylnitril oder acrylnitrilhaltigen mischpolymerisaten |
| GB1415682A (en) * | 1972-06-30 | 1975-11-26 | Wyeth John & Brother Ltd | Amides and thioamides |
| GB1420758A (en) * | 1972-07-12 | 1976-01-14 | Wyeth John & Brother Ltd | Anti-ulcer compositions |
| US3968211A (en) * | 1974-02-11 | 1976-07-06 | The Upjohn Company | Compositions and methods of use of amidines for anti-arrhythmic purposes |
| JPS5344573A (en) * | 1976-10-01 | 1978-04-21 | Teijin Ltd | Optical active 2-piperidineethanols and their preparation |
| US4316903A (en) * | 1977-07-18 | 1982-02-23 | Merck & Co., Inc. | Anti-microbial piperidino buten-2-ones |
| JPS55129255A (en) * | 1979-03-28 | 1980-10-06 | Kuraray Co Ltd | Farnesylacetamide compounds or their salts |
| DE2947649A1 (de) * | 1979-11-27 | 1981-08-06 | C.F. Spiess & Sohn GmbH & Co, 6719 Kleinkarlbach | Insektizide mittel |
| US4565819A (en) * | 1979-12-07 | 1986-01-21 | Adir | Substituted imino diacids, their preparation and pharmaceutical compositions which contain them |
| US4326067A (en) * | 1980-12-03 | 1982-04-20 | The Dow Chemical Company | Process for making N-(2-aminoethyl)amides |
| US4695575A (en) * | 1984-11-13 | 1987-09-22 | Janssen Pharmaceutica, N.V. | 4-[(bicycle heterocyclyl)-methyl and -hetero]-piperidines |
| DE3433036A1 (de) * | 1984-09-08 | 1986-03-20 | Basf Ag, 6700 Ludwigshafen | Piperidinderivate und diese enthaltende fungizide sowie verfahren zur bekaempfung von pilzen |
| US4812451A (en) * | 1984-10-19 | 1989-03-14 | A. H. Robins Company, Incorporated | 1-(aminoalkyl and aminoalkylamino)carbonyl and thiocarbonyl)-α,.alpha. |
| US4906659A (en) * | 1985-06-18 | 1990-03-06 | Takeda Chemical Industries, Ltd. | Antibiotic tan-749, its derivatives, production and use thereof |
| ES2053527T3 (es) * | 1986-02-01 | 1994-08-01 | Nippon Chemiphar Co | Derivados de alquilendiamina. |
| DE3814549A1 (de) * | 1987-10-30 | 1989-05-18 | Bayer Ag | N-substituierte derivate von 1-desoxynojirimycin und 1-desoxymannonojirimycin, verfahren zu deren herstellung und deren verwendung in arzneimitteln |
| DK168069B1 (da) * | 1987-11-11 | 1994-01-31 | Hoffmann La Roche | Isoquinolinderivater og en fremgangsmaade til fremstilling af octahydroisoquinoliner ud fra derivaterne |
| FR2649490B1 (fr) * | 1989-07-07 | 1991-09-20 | Thomson Csf | Capteur de rayonnement d'energie electromagnetique |
| CA2025490C (en) * | 1989-09-22 | 2003-09-16 | James R. Mccarthy | Novel substituted alkyl piperidines and their use as inhibitors of cholesterol synthesis |
| EP0421441B1 (de) * | 1989-10-06 | 1995-01-25 | Fujirebio Inc. | Pantothensäure Derivate |
| NZ239023A (en) * | 1990-07-24 | 1993-12-23 | Merrell Dow Pharma | N-substituted-hydroxyalkyl piperidine derivatives and pharmaceutical |
| NZ239022A (en) * | 1990-07-25 | 1993-11-25 | Merrell Dow Pharma | Piperidyl ethers and thioethers; preparatory processes and pharmaceutical compositions |
| CA2048110C (en) * | 1990-07-30 | 2002-06-25 | Muneo Takatani | Imidazopyridine derivatives and their use |
| US5084461A (en) * | 1991-03-27 | 1992-01-28 | Merrell Dow Pharmaceuticals Inc. | Azadecalin amides and thioamides as inhibitors of cholesterol biosynthesis |
-
1992
- 1992-12-18 US US07/993,497 patent/US5350758A/en not_active Expired - Fee Related
-
1993
- 1993-06-03 AU AU44037/93A patent/AU678973B2/en not_active Ceased
- 1993-06-03 KR KR1019950700066A patent/KR100286410B1/ko not_active Expired - Fee Related
- 1993-06-03 EP EP93914338A patent/EP0650474B1/de not_active Expired - Lifetime
- 1993-06-03 NZ NZ253592A patent/NZ253592A/en unknown
- 1993-06-03 AT AT93914338T patent/ATE169618T1/de not_active IP Right Cessation
- 1993-06-03 WO PCT/US1993/005265 patent/WO1994001404A1/en not_active Ceased
- 1993-06-03 DE DE69320352T patent/DE69320352T2/de not_active Expired - Fee Related
- 1993-06-03 JP JP6502739A patent/JPH07508732A/ja active Pending
- 1993-06-03 CA CA002136841A patent/CA2136841C/en not_active Expired - Fee Related
- 1993-06-03 ES ES93914338T patent/ES2120506T3/es not_active Expired - Lifetime
- 1993-07-02 ZA ZA934777A patent/ZA934777B/xx unknown
- 1993-07-05 IL IL106237A patent/IL106237A0/xx unknown
- 1993-07-07 MX MX9304070A patent/MX9304070A/es not_active IP Right Cessation
-
1994
- 1994-05-25 US US08/248,894 patent/US5489600A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU678973B2 (en) | 1997-06-19 |
| DE69320352D1 (de) | 1998-09-17 |
| KR950702534A (ko) | 1995-07-29 |
| MX9304070A (es) | 1994-02-28 |
| ZA934777B (en) | 1994-01-20 |
| AU4403793A (en) | 1994-01-31 |
| EP0650474B1 (de) | 1998-08-12 |
| WO1994001404A1 (en) | 1994-01-20 |
| CA2136841C (en) | 1998-10-06 |
| ES2120506T3 (es) | 1998-11-01 |
| JPH07508732A (ja) | 1995-09-28 |
| US5350758A (en) | 1994-09-27 |
| US5489600A (en) | 1996-02-06 |
| CA2136841A1 (en) | 1994-01-20 |
| IL106237A0 (en) | 1993-11-15 |
| DE69320352T2 (de) | 1998-12-17 |
| EP0650474A1 (de) | 1995-05-03 |
| NZ253592A (en) | 1996-04-26 |
| KR100286410B1 (ko) | 2001-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0687183A4 (de) | Synergistische zusammensetzung bestehend aus einem auf cd4-basierendem protein und anti-hiv-1-antikörper, und methoden zu deren verwendung | |
| TR200101867T2 (tr) | CCR5 modülatörleri olarak piperidinler | |
| ATE296799T1 (de) | P38-inhibitoren | |
| DE69118028D1 (de) | Neue 2,6-Dialkyl-4-silyl-phenole als antiatherosclerotische Mittel und als Antioxidantien | |
| EP1155121A4 (de) | Zusammensetzungen und verfahren zur regulierung des serumcholesterins | |
| TR199801255T2 (xx) | Vitronektin resept�r antagonistleri. | |
| ES2133807T3 (es) | Compuestos de peptidilo y su uso terapeutico como inhibidores de metaloproteasas. | |
| TR200000015T2 (tr) | Bileşikler ve metodlar | |
| BR9713338A (pt) | Benzonaftiridinas como terapêuticos brÈnquicos. | |
| DK1039912T3 (da) | Angiostatiske midler og præparater til behandling af GLC1A-glaukom | |
| BR9811589A (pt) | Derivados de hidroxicumaranona o-substituìda como agentes antitumores e antimetastáticos | |
| DE69733843D1 (de) | Zusammensetzungen und verwendungvon benzamiden als entzuendungshemmende mittel | |
| DE69915634D1 (de) | Tricyclische sulfonamide und ihre derivate als inhibitoren von matrix-metalloproteinasen | |
| DE69320352D1 (de) | Piperidinylamide, sulfonamide und sulfoxamide als inhibitoren der cholesterin biosynthese | |
| ATE249831T1 (de) | Carboxamidderivate von pyrrolidine und piperidine als urotensin-ii rezeptorantagonisten | |
| AU644458B2 (en) | Novel piperidyl ethers and thioethers as inhibitors of cholesterol biosynthesis | |
| DE3889302D1 (de) | 9-(Acylamino)tetrahydroacridinderivate und wahrnehmungssteigernde Mittel davon als aktiver Wirkstoff. | |
| DK0556322T3 (da) | Aminosulfonylurinstof-ACAT-inhibitorer | |
| FR2825273B1 (fr) | Composition pour le traitement des signes cutanes du vieillissement | |
| DE60019117D1 (de) | Substituierte benzamide als inhibitoren von rhinovirus 3c protease | |
| ATE28188T1 (de) | Antikonvulsive mittel. | |
| ATE354591T1 (de) | Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen | |
| DE59808166D1 (de) | Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure als mukolytikum | |
| DE69230644D1 (de) | Verwendung von protease nexin-i als mittel gegen entzündungen | |
| MXPA02007787A (es) | Moleculas trade y uso relacionado con las mismas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |